EURACTIV9mon
Limiting competition in medicines is not an option
The European Commission estimates that reducing ... by having even longer periods of no competition for new medicines, in the hope of boosting research and production in Europe even though this ...
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...
Reuters27d
Bayer submits EU marketing application for menopause relief drug
Oct 15 (Reuters) - Bayer (BAYGn.DE), opens new tab on Tuesday said it had applied for marketing authorization with the European Medicines Agency ... intense home loan competition, rising costs ...